Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7406 USD | -0.01% | -0.46% | +32.25% |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Matthew Davis
COO | Chief Operating Officer | - | 22-06-30 |
Paul Spencer
IRC | Investor Relations Contact | - | 22-11-30 |
William Clementi
PRN | Corporate Officer/Principal | - | 23-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 194,612,289 | 64,188,859 ( 32.98 %) | 0 | 32.98 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ACCUSTEM SCIENCES, INC. 11.80% | 1,337,970 | 11.80% | 445,544 $ |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.25% | 74.3M | |
+69.51% | 62.86B | |
-0.92% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.45% | 26.46B | |
-22.25% | 18.9B | |
+4.51% | 12.67B | |
+24.08% | 12.27B | |
+28.21% | 12.07B |
- Stock Market
- Equities
- TLSA Stock
- Company Tiziana Life Sciences Ltd